Filippo Drago
#116,259
Most Influential Person Now
Italian pharmacologist
Filippo Drago 's AcademicInfluence.com Rankings
Filippo Drago medical Degrees
Medical
#1752
World Rank
#2125
Historical Rank
Pharmacology
#197
World Rank
#237
Historical Rank
Download Badge
Medical
Filippo Drago 's Degrees
- Bachelors Pharmacology University of Milan
- Masters Pharmacology University of Milan
Why Is Filippo Drago Influential?
(Suggest an Edit or Addition)According to Wikipedia, Filippo Drago is an Italian pharmacologist, neurologist and psychiatrist. He is a professor of pharmacology at the University of Catania, Italy. Filippo Drago has several patents in the field of pharmacology and is author of more than 500 papers published in peer-reviewed journals.
Filippo Drago 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials (2014) (369)
- Isoflavones: estrogenic activity, biological effect and bioavailability (2013) (322)
- New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. (2012) (294)
- Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. (2010) (243)
- Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms (2014) (220)
- Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels (2006) (213)
- Identification of Dopamine D1–D3 Receptor Heteromers (2008) (203)
- Potential role of probiotics on colorectal cancer prevention (2012) (200)
- Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels (2009) (192)
- Endocannabinoid system and mood disorders: priming a target for new therapies. (2013) (187)
- Epigenetic Modulation of mGlu2 Receptors by Histone Deacetylase Inhibitors in the Treatment of Inflammatory Pain (2009) (176)
- International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets (2018) (173)
- Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. (2013) (148)
- Oxytocin potently enhances novelty-induced grooming behavior in the rat (1986) (137)
- Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. (2003) (124)
- Moderate Physical Activity as a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological Key (2019) (123)
- Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. (2009) (123)
- Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression (2010) (120)
- Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. (2012) (116)
- Prenatal stress induces body weight deficit and behavioural alterations in rats: the effect of diazepam (1999) (116)
- Mechanism and clinical significance of prostaglandin-induced iris pigmentation. (2002) (111)
- Antioxidants as Antidepressants (2012) (110)
- Dopamine D(3) receptor as a new pharmacological target for the treatment of depression. (2013) (110)
- Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects (2013) (107)
- Endocannabinoids and neurodegenerative diseases. (2007) (105)
- Neurobiological links between depression and AD: The role of TGF‐&bgr;1 signaling as a new pharmacological target (2018) (104)
- Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer's Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective (2011) (101)
- The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (2011) (101)
- Ocular drug delivery: a clue from nanotechnology (2012) (101)
- TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease (2011) (96)
- A key role for TGF-β1 in hippocampal synaptic plasticity and memory (2015) (93)
- Red Orange: Experimental Models and Epidemiological Evidence of Its Benefits on Human Health (2013) (92)
- Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection (2011) (91)
- Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach (2019) (88)
- Endocannabinoid system, stress and HPA axis. (2018) (88)
- The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. (2010) (87)
- Systemic and intraventricular prolactin induces excessive grooming. (1980) (85)
- Current drug treatments targeting dopamine D3 receptor. (2016) (84)
- Evaluation of CHI3L-1 and CHIT-1 Expression in Differentiated and Polarized Macrophages (2013) (84)
- Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. (2013) (82)
- Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach (2015) (78)
- Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies. (2018) (77)
- Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract. (2011) (77)
- Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study (2017) (77)
- Beneficial effects of the Mediterranean diet on metabolic syndrome. (2014) (75)
- Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery (2013) (75)
- Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1 (2019) (72)
- Small Doses of Melatonin Increase Intestinal Motility in Rats (2002) (71)
- Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. (2016) (68)
- Pharmacological management of ocular hypertension: current approaches and future prospective. (2013) (68)
- TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway (2008) (68)
- Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission (2006) (67)
- Protective role of the Mediterranean diet on several cardiovascular risk factors: evidence from Sicily, southern Italy. (2014) (67)
- Prolactin induces grooming in the rat: Possible involvement of nigrostriatal dopaminergic system (1981) (67)
- Behavioral effects of phosphatidylserine in aged rats (1981) (67)
- Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation (2012) (67)
- P2X7 receptor antagonism: Implications in diabetic retinopathy (2017) (66)
- The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. (2014) (66)
- Prenatal stress alters glutamatergic system responsiveness in adult rat prefrontal cortex (2009) (65)
- Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit. (2015) (64)
- Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. (2013) (64)
- Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. (2014) (64)
- Prolactin and sexual behavior: A review (1984) (63)
- Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway. (2015) (62)
- The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review (2020) (62)
- Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2‐mediated activation of the Nrf2/HO‐1 pathway (2019) (62)
- The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy (2010) (60)
- Therapeutic potential of cannabinoids in schizophrenia. (2014) (59)
- Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone (2014) (59)
- Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs? (2007) (58)
- Protective effects of a coumarin derivative in diabetic rats. (2009) (57)
- Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditions. (2015) (57)
- Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect. (2004) (56)
- Anorectal mucosal melanoma (2018) (56)
- Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). (2005) (55)
- Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats (2012) (55)
- Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. (2010) (54)
- Spatial Learning Potentiates the Stimulation of Phosphoinositide Hydrolysis by Excitatory Amino Acids in Rat Hippocampal Slices (1988) (54)
- Factors Associated with Colorectal Cancer in the Context of the Mediterranean Diet: A Case-Control Study (2014) (54)
- Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study. (2018) (54)
- Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: Behavioral and neurochemical studies in rats (2009) (54)
- Elevated serum levels of Chromogranin A in hepatocellular carcinoma (2012) (54)
- Sigma receptor ligands protect human retinal cells against oxidative stress (2006) (54)
- Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients (2014) (54)
- Low levels of 17-β-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case–control study (2014) (54)
- Carbon monoxide and the eye: Implications for glaucoma therapy. (2011) (53)
- Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas. (2019) (53)
- Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure. (2015) (52)
- The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice. (1999) (51)
- Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice (2017) (51)
- Chronic Antidepressants Induce Redistribution and Differential Activation of αCaM Kinase II between Presynaptic Compartments (2007) (51)
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia (2017) (51)
- Grooming Behavioral Effects of Oxytocin (1988) (51)
- Latanoprost exerts neuroprotective activity in vitro and in vivo. (2001) (50)
- Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems (2021) (50)
- PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina (2015) (50)
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia (2019) (49)
- Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus. (2017) (49)
- Short-term endogenous hyperprolactinaemia and sexual behavior of male rats (1981) (49)
- Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of sigma1 recognition sites. (2004) (49)
- Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough. (2012) (48)
- PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways. (2014) (48)
- Homocysteine Serum Levels in Diabetic Patients with Non Proliferative, Proliferative and without Retinopathy (2014) (48)
- Endogenous hyperprolactinaemia and avoidance behaviors of the rat (1982) (47)
- Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat (1986) (47)
- In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist (2009) (46)
- Endogenous hyperprolactinaemia enhances amphetamine- and apomorphine-induced stereotypy. (1981) (45)
- Prolactin inhibits the development of stress-induced ulcers in the rat. (1985) (45)
- PKCbetaII/HuR/VEGF: A new molecular cascade in retinal pericytes for the regulation of VEGF gene expression. (2008) (44)
- Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (2009) (44)
- Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia (2006) (44)
- The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression (2012) (44)
- Biosimilar drugs : concerns and opportunities. (2007) (44)
- alpha-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro. (1999) (43)
- Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 (2019) (43)
- Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages (2019) (43)
- Fortified Extract of Red Berry, Ginkgo biloba, and White Willow Bark in Experimental Early Diabetic Retinopathy (2013) (42)
- A New Human Blood–Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes (2020) (42)
- Folate status in type 2 diabetic patients with and without retinopathy (2015) (42)
- Acute low doses of melatonin restore full sexual activity in impotent male rats (2000) (42)
- The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats. (2012) (42)
- Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST) (2008) (41)
- Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems (2012) (41)
- A flibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway. (2019) (41)
- Pharmacokinetics and bioavailability of a Ginkgo biloba extract. (2002) (41)
- Long-lasting behavioral changes induced by pre- or neonatal exposure to diazepam in rats. (2003) (40)
- EFFECTS OF OPIATES AND OPIOIDS ON INTRAOCULAR PRESSURE OF RABBITS AND HUMANS (1985) (40)
- Hyperprolactinemia-induced excessive grooming in the rat: time-course and element analysis. (1981) (40)
- Sexual dimorphism in passive avoidance behavior of rats: Relation to body weight, age, shock intensity and retention interval (1980) (39)
- Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1 (2016) (38)
- Prolactin as a protective factor in stress‐induced biological changes (1989) (38)
- Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols (2017) (38)
- MicroRNA target prediction in glaucoma. (2015) (38)
- Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence (2015) (38)
- Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats (2009) (38)
- Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells (2017) (38)
- The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy. (2012) (38)
- Prolactin-enhanced grooming behavior: Interaction with ACTH (1983) (38)
- Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy (2018) (37)
- Three years of experience: the Italian registry and safety data update (2010) (37)
- Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats (1990) (37)
- Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions (2008) (36)
- Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes (2015) (36)
- Long-Term Exposure to the Atypical Antipsychotic Olanzapine Differently Up-Regulates Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylation in Subcellular Compartments of Rat Prefrontal Cortex (2006) (36)
- The Role of Neutrophils in Corneal Wound Healing in HO-2 Null Mice (2011) (36)
- Resveratrol in Patients with Minimal Hepatic Encephalopathy (2018) (36)
- When nanotechnology meets the ocular surface (2008) (36)
- TGF-β1 prevents rat retinal insult induced by amyloid-β (1-42) oligomers. (2016) (36)
- Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? (2001) (36)
- Sulodexide prevents activation of the PLA2/COX‐2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE (2017) (36)
- Antiproliferative Effects of PACAP and VIP in Serum-Starved Glioma Cells (2013) (35)
- Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women. (2007) (35)
- Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene (2014) (35)
- Retinal Protection and Distribution of Curcumin in Vitro and in Vivo (2018) (35)
- Localized lipoatrophy after prolonged treatment with copolymer 1 (2000) (35)
- Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats (2017) (34)
- Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. (2003) (34)
- The β3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes (2010) (33)
- The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans (2019) (33)
- The "low-dose" concept and the paradoxical effects of prolactin on grooming and sexual behavior. (2000) (33)
- A comparison of grooming behavior potencies of neurohypophyseal nonapeptides (1986) (33)
- Effect of chitinase inhibitors on endotoxin-induced uveitis (EIU) in rabbits. (2008) (32)
- A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice (2020) (32)
- Eating disorders as a public health issue: Prevalence and attributable impairment of quality of life in an Italian community sample (2014) (32)
- Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection. (2005) (32)
- Alternative Splicing Generates Different Parkin Protein Isoforms: Evidences in Human, Rat, and Mouse Brain (2014) (32)
- Effects of calcitonin, parathyroid hormone and its related fragments on acquisition of active avoidance behavior (1984) (31)
- Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells. (2016) (31)
- P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice. (2020) (30)
- Expression profile of parkin isoforms in human gliomas. (2015) (30)
- Depression in older breast cancer survivors (2012) (30)
- Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide‐induced ocular inflammation (2014) (30)
- Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration. (1986) (30)
- Long-lasting neurotoxicity of prenatal benzene acute exposure in rats. (2006) (30)
- Blood-retinal barrier protection against high glucose damage: the role of P2X7 receptor. (2019) (30)
- Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer’s Disease: Implications for the Treatment (2013) (29)
- Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors (2020) (29)
- Effects of cytidine-diphosphocholine on acetylcholine-mediated behaviors in the rat (1993) (29)
- Acute low doses of melatonin stimulate rat sex behavior: the role of serotonin neurotransmission. (1999) (29)
- Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam (2015) (29)
- Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery (2018) (29)
- Novel Therapeutics in Glaucoma Management (2018) (29)
- Antioxidant and Osmoprotecting Activity of Taurine in Dry Eye Models. (2017) (29)
- Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment. (2020) (29)
- Controversies in Glaucoma: Current Medical Treatment and Drug Development. (2015) (28)
- Effects of hyperprolactinaemia on core temperature of the rat (1984) (28)
- Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance (2017) (28)
- Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence (2020) (28)
- Gabapentin Attenuates Ocular Inflammation: In vitro and In vivo Studies (2017) (28)
- Acidic Mammalian Chitinase and the Eye: Implications for Ocular Inflammatory Diseases (2011) (28)
- Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases (2017) (28)
- Effects of cerebellectomy on motivation-related behavior: A time-course study (1993) (28)
- New drugs in psychiatry: focus on new pharmacological targets (2017) (28)
- Effects of COOH–Terminal Tripeptide –MSH11–13 on Corneal Epithelial Wound Healing: Role of Nitric Oxide (2006) (28)
- Lipoprotein(a) Serum Levels in Diabetic Patients with Retinopathy (2013) (28)
- Dual effect of female sex steroids on drug-induced gastroduodenal ulcers in the rat. (1999) (28)
- Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam (2011) (27)
- Ocular pharmacokinetics profile of different indomethacin topical formulations. (2011) (27)
- Effects of Vitamin D3 in Long-Term Ovariectomized Rats Subjected to Chronic Unpredictable Mild Stress: BDNF, NT-3, and NT-4 Implications (2019) (27)
- Adrenomedullin and ocular inflammation in the rabbit. (2000) (26)
- A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits (2007) (26)
- Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia (2020) (26)
- Activation of the VEGF-A/ERK/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy (2020) (26)
- Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile (2020) (26)
- Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death (2014) (25)
- Regulation of vascular tone in rabbit ophthalmic artery: cross talk of endogenous and exogenous gas mediators. (2014) (25)
- TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy (2020) (25)
- Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia Activation (2019) (25)
- Behavioral effects of amylin injected intracerebroventricularly in the rat (1996) (25)
- Comparative effects of amitriptyline and amineptine in patients affected by anxious depression. (1995) (25)
- Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa (2019) (25)
- Behavioral responses of long-term hyperprolactinaemic rats. (1982) (25)
- Quality of life and urban / rural living: preliminary results of a community survey in Italy. (2012) (24)
- The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice. (2016) (24)
- The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy (2015) (24)
- Influence of Trace Elements on Neurodegenerative Diseases of The Eye—The Glaucoma Model (2021) (24)
- Amphetamine-induced analgesia does not involve brain opioids. (1984) (24)
- Binge-like eating in mice. (2009) (24)
- Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System (2019) (24)
- Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial (2014) (24)
- Pharmacological and dietary prevention for colorectal cancer (2013) (23)
- Effects of centrally injected amylin on sexual behavior of male rats (1999) (23)
- PACAP Interacts with PAC1 Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures (2015) (23)
- Effects of calcitonin gene-related peptide on extrapyramidal motor system (1992) (23)
- A new nomenclature for classifying psychotropic drugs. (2017) (23)
- Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? (2020) (22)
- Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin. (2015) (22)
- Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits. (2006) (22)
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in perinatal Δ9-tetrahydrocannabinol occurs in schizophrenia: analyses in patients and in animal model of the disease. (2020) (22)
- A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors. (2006) (22)
- Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress (2021) (22)
- Expression pattern of parkin isoforms in lung adenocarcinomas (2015) (22)
- Effects of acute or chronic administration of risperidone on motor and sexual behavior of male rats. (1997) (22)
- Biosimilar Drugs (2012) (22)
- Inhibition of rat glioma cell migration and proliferation by a calix[8]arene scaffold exposing multiple GlcNAc and ureido functionalities (2008) (22)
- Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man (1993) (22)
- NAP Reduces Murine Microvascular Endothelial Cells Proliferation Induced by Hyperglycemia (2014) (22)
- Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study (2020) (22)
- Neuroactive steroids protect retinal pigment epithelium against oxidative stress (2005) (21)
- Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis (2017) (21)
- Conditioned place preference: no tolerance to the rewarding properties of morphine (1997) (21)
- Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder (2011) (21)
- Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats (2019) (21)
- Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade (2017) (21)
- Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability (2016) (21)
- Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression? (2020) (21)
- Damaging actions of testosterone on cysteamine-induced gastroduodenal ulceration and vascular leakage in the rat. (1997) (20)
- Hysterical neurosis of the conversion type: therapeutic activity of neuroleptics with different hyperprolactinemic potency. (1996) (20)
- Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells. (2020) (20)
- The Block of Central Vasopressin V1 but not V2 Receptors Suppresses Grooming Behavior and Hypothermia Induced by Intracerebroventricular Vasopressin in Male Rats (1997) (20)
- Neurofibromin and Amyloid Precursor Protein Expression in Dopamine D3 Receptor Knock-Out Mice Brains (2011) (20)
- Morphine-induced ocular hypotension is modulated by nitric oxide and carbon monoxide: role of mu3 receptors. (2010) (20)
- Protein kinase C activation affects, via the mRNA-binding Hu-antigen R/ELAV protein, vascular endothelial growth factor expression in a pericytic/endothelial coculture model (2012) (20)
- Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? (2017) (20)
- Vestibular compensation in aged rats with unilateral labyrinthectomy treated with dopaminergic drugs. (1996) (19)
- Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks (2008) (19)
- Single Photon Emission Computed Tomography Striatal Asymmetry Index May Predict Dopaminergic Responsiveness in Parkinson Disease (2011) (19)
- Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments (2020) (19)
- Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury (2006) (19)
- Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate (2015) (19)
- Catecholamine utilization in specific rat brain nuclei after short-term hyperprolactinaemia (1984) (19)
- Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval? (2021) (19)
- Acetylcarnitine reduces the immobility of rats in a despair test (constrained swim). (1990) (19)
- Behavioral effects of acetyl-l-carnitine in the male rat (1986) (19)
- Dopamine-₃ receptor modulates intraocular pressure: implications for glaucoma. (2012) (19)
- Central serotonin2B receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow (2015) (18)
- Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells. (2013) (18)
- Effects of hyaluronan on free-radical formation, corneal endothelium damage, and inflammation parameters after phacoemulsification in rabbits. (2004) (18)
- Effects of RGH 2202 on cognitive and motor behavior of the rat (1996) (18)
- Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats (2000) (18)
- Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers? (2014) (18)
- Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications (2015) (18)
- Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease (2019) (18)
- Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation. (2015) (17)
- Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage (2021) (17)
- The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice (2019) (17)
- Serotonin nerve endings and regulation of pupillary diameter. (1981) (17)
- Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice (2021) (17)
- Effects of vinburnine on experimental models of learning and memory impairments (1990) (17)
- Effects of sulfinpyrazone on retinal damage induced by experimental diabetes mellitus in rabbits. (1998) (17)
- The inhibition of oxytocin-induced grooming by a specific receptor antagonist (1991) (17)
- Opiate receptors in the rabbit iris (2004) (17)
- Dopaminergic‐GABAergic interplay and alcohol binge drinking (2019) (17)
- Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. (2006) (17)
- Enhanced expression of ERα in astrocytes modifies the response of cortical neurons to β-amyloid toxicity (2009) (17)
- Reduced activation of intracellular signaling pathways in rat prefrontal cortex after chronic phencyclidine administration. (2008) (16)
- Effects of Pregnancy in Rats on Cysteamine-Induced Peptic Ulcers (Role of Progesterone) (1997) (16)
- Tackling dipeptidyl peptidase IV in neurological disorders (2018) (16)
- Naltrexone-sensitive behavioral actions of the ACTH 4-9 analog (Org 2766). (1983) (16)
- Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor (2020) (16)
- NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage (2018) (16)
- Therapeutic potential of nitric oxide modulation in ocular diseases. (2010) (16)
- Ocular Expression of Type‐I Pituitary Adenylate Cyclase‐ Activating Polypeptide (PACAP) Receptors a (1996) (16)
- Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline. (2013) (16)
- Dual effects of melatonin on barbiturate-induced narcosis in rats (2001) (15)
- Behavioral and neurochemical effects of dopaminergic drugs in models of brain injury (2002) (15)
- Effect of dopamine agonists and antagonists on neurotensin-induced antinociception (1986) (15)
- Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits. (2007) (15)
- Behavioral effects of deprenyl in aged rats. (1986) (15)
- The Impact of Prulifloxacin on Vaginal Lactobacillus Microflora: An In Vivo Study (2009) (15)
- Effects of oxytocin on emotional stress and stress-induced gastric lesions (1993) (15)
- D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis (2018) (14)
- New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin (2020) (14)
- The pharmacovigilance program on natalizumab in Italy: 2 years of experience (2009) (14)
- Effects of PPARγ ligands on vascular tone. (2012) (14)
- Long-term efficacy of latanoprost in primary congenital glaucoma (2014) (14)
- Modulation of C6 Glioma Cell Proliferation by Ureido-Calix[8]arenes (2010) (14)
- 1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice (2021) (14)
- Epigenetic drugs for Alzheimer's disease: hopes and challenges. (2013) (14)
- Effects of mastectomy and vagotomy on grooming behavior of the rat: Possible involvement of prolactin (1984) (14)
- In vivo and in vitro interference of phosphatidylserine liposomes on prolactin secretion in the rat. (1981) (14)
- COVID-19 Disease and Vitamin D: A Mini-Review (2020) (14)
- The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience (2020) (14)
- BEHAVIORAL EFFECTS OF PROLACTIN: INVOLVEMENT OF OPIOID RECEPTORS (1981) (13)
- Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant. (2013) (13)
- Comparing factor structure of the Mood Disorder Questionnaire (MDQ): In Italy sexual behavior is euphoric but in Asia mysterious and forbidden. (2014) (13)
- Pyroglutamic acid improves learning and memory capacities in old rats. (1988) (13)
- Natalizumab: a country-based surveillance program (2008) (13)
- Riluzole restores motor activity in rats with post-traumatic peripheral neuropathy (2004) (13)
- Circulating miRNAs in diabetic retinopathy patients: prognostic markers or pharmacological targets? (2021) (13)
- Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography–electrospray tandem mass spectrometry (2011) (13)
- The Role of Prolactin in Rat Grooming Behavior (1988) (13)
- Behavioral and neurochemical alterations induced by reversible conductive hearing loss in aged male rats (1996) (13)
- Aromatization of testosterone by adipose tissue and sexual behavior of castrated male rats. (1982) (13)
- Oral Echinacea purpurea extract in low-grade, steroid-dependent, autoimmune idiopathic uveitis: a pilot study. (2006) (12)
- Hippocampal Neurofibromin and Amyloid Precursor Protein Expression in Dopamine D3 Receptor Knock-out Mice Following Passive Avoidance Conditioning (2013) (12)
- New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review (2021) (12)
- Quantitative alteration of grooming behavior in aged male rats (1985) (12)
- Nicergoline facilitates vestibular compensation in aged male rats with unilateral labyrinthectomy (1999) (12)
- Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition (2021) (12)
- Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment. (2021) (12)
- Effects of endogenous hyperprolactinaemia on opiate-induced behavioral changes in rats (1985) (12)
- Does Mood Disorder Questionnaire identify sub-threshold bipolarity? Evidence studying worsening of quality of life. (2015) (12)
- Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome (2017) (12)
- Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study. (2016) (12)
- The Prevalence of Specific Phobia by Age in an Italian Nationwide Survey: How Much Does it Affect the Quality of Life? (2019) (11)
- Clinical pharmacology of novel anti-Alzheimer disease modifying medications. (2013) (11)
- Intravenous Maprotiline in Severe and Resistant Primary Depression: A Double-Blind Comparison with Clomipramine (1983) (11)
- Focus on molecules: heme oxygenase-1. (2009) (11)
- Inverse agonists – What do they mean for psychiatry? (2017) (11)
- Phospholipid liposomes potentiate the inhibitory effect of antidepressant drugs on immobility of rats in a despair test (constrained swim). (1985) (11)
- An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting (2020) (11)
- Behavioral effects of L-α-glycerylphosphorylcholine: Influence on cognitive mechanisms in the rat (1992) (11)
- Memory deficits of aged male rats can be improved by pyrimidine nucleosides and n-acetyl-glutamine. (1990) (11)
- Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries (2017) (11)
- Behavioral effects of perinatal administration of antidepressant drugs in the rat. (1985) (10)
- Hormonal modulation of central dopaminergic transmission. (1986) (10)
- Effects of calcitonin on morphine tolerance and withdrawal syndrome in morphine physically dependent rats. (1989) (10)
- Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis (2018) (10)
- Comparative bioavailability of different formulations of levothyroxine and liothyronine in healthy volunteers (2006) (10)
- Endozepine-4 levels are increased in hepatic coma. (2015) (10)
- Pharmacokinetics of a new subcutaneous diclofenac formulation administered to three body sites: quadriceps, gluteus, and abdomen. (2014) (9)
- Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap (2020) (9)
- Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas (2015) (9)
- Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity. (2015) (9)
- Endothelium-dependent vasomotor effects of telmisartan in isolated rat femoral arteries. (2011) (9)
- Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue (2021) (9)
- Prolactin as a Protective Factor in Stress‐Induced Gastric Ulcers (1990) (9)
- Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. (2017) (9)
- The P2X7 receptor as a new pharmacological target for retinal diseases. (2022) (9)
- Dose-dependent effects of acute kainic acid treatment on sexual behavior of male rats (1997) (9)
- Behavioral and endocrine effects of growth hormone administration in aged female rats (1996) (9)
- Side effects of drugs stimulating prolactin secretion on the behavior of male rats. (1985) (9)
- Layer-specific potentiation of network GABAergic inhibition in the CA1 area of the hippocampus (2016) (9)
- Pharmacological significance of extra-oral taste receptors. (2021) (8)
- Effects of beta-blockers association with pilocarpine on rabbit intraocular pressure and heart rate. (1997) (8)
- Impairment of Quality of Life Associated With Lifetime Diagnosis of Post-traumatic Stress Disorder in Women - A National Survey in Italy (2019) (8)
- Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System (2018) (8)
- The lifetime prevalence and impact of generalized anxiety disorders in an epidemiologic Italian National Survey carried out by clinicians by means of semi-structured interviews (2021) (8)
- New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery (2020) (8)
- Effects of flunarizine on experimentally-induced convulsions in animals. (1986) (8)
- Tin chloride enhances parvalbumin-positive interneuron survival by modulating heme metabolism in a model of cerebral ischemia (2011) (8)
- Behavioral effects of L-alpha-glycerylphosphorylcholine: influence on cognitive mechanisms in the rat. (1992) (8)
- Increased Hippocampal CREB Phosphorylation in Dopamine D3 Receptor Knockout Mice Following Passive Avoidance Conditioning (2013) (8)
- Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic Retinopathy (2021) (8)
- Diclofensine in the treatment of depressed geriatric hospitalized patients: a placebo-controlled double-blind trial (1984) (8)
- Ocular instillation of naloxone increases intraocular pressure in morphine-addicted patients: A possible test for detecting misuse of morphine (1985) (8)
- Vitamin D and Depression in Women: A Mini-review (2019) (7)
- Role of prolactin-opiate interactions in the central regulation of pain threshold (1983) (7)
- Parasomnias, sleep-related movement disorders and physiological sleep variants in focal epilepsy: A polysomnographic study (2020) (7)
- Neuroactive Steroids Protect Retinal Tissue through σ1 Receptors (2007) (7)
- Behavioral changes induced by the thyrotropin-releasing hormone analogue, RGH 2202 (1991) (7)
- Effects of haloperidol on morphine-induced antinociception morphine tolerance and withdrawal in hyperprolactinaemic rats (1985) (7)
- New definition of addiction proposed by the American Society of Addiction Medicine: Which implications for the treatment of tobacco dependence? (2014) (7)
- Influence of growth hormone on cysteamine-induced gastro-duodenal lesions in rats: the involvement of somatostatin. (1997) (7)
- Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis (2018) (7)
- Intracerebroventricular injection of anti-prolactin serum suppresses excessive grooming of pituitary homografted rats. (1986) (7)
- Neuroactive steroids protect retinal tissue through sigma1 receptors. (2007) (7)
- Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease (2021) (7)
- Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries (2021) (7)
- Parkin Expression Profile in Dopamine D3 Receptor Knock-Out Mice Brains (2009) (6)
- Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study (2020) (6)
- Long-Term Exposure to the Atypical Antipsychotic Olanzapine Differently UpRegulates Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylation in Subcellular Compartments of Rat Prefrontal Cortex (2006) (6)
- Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database (2021) (6)
- Effects of TRH-T on spinal motoneurones in man. (1992) (6)
- Role of D1 and D2 receptors in the regulation of intraocular pressure. (1990) (6)
- The Apathy Evaluation Scale (AES-C): Psychometric Properties and Invariance of Italian Version in Mild Cognitive Impairment and Alzheimer’s Disease (2021) (6)
- Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. (2022) (6)
- Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR). (2020) (6)
- Linking the Price of Cancer Drug Treatments to Their Clinical Value (2016) (6)
- Protective action of phosphatidylserine on stress-induced behavioral and autonomic changes in aged rats (1991) (6)
- Behavioral and neurochemical changes in long-term hyperprolactinemia. (1985) (5)
- Neuroendocrine and Behavioral Effects of Flunarizine in Young and Old Rats (1985) (5)
- Faculty Opinions recommendation of Pimavanserin: Potential Treatment For Dementia-Related Psychosis. (2020) (5)
- Biochemical changes induced by pyrphenoxone in the lens of rabbits and rats. (1995) (5)
- Growth hormone and somatostatin interaction in the ulcerogenic effect of cysteamine in female rats (1997) (5)
- The effects of acetyl-l-carnitine on experimental models of learning and memory deficits in the old rat. (1989) (5)
- Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin. (1997) (5)
- Thymic factors influence on behavior in rodents (1993) (5)
- Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome (2018) (5)
- Effect of sulpiride on chronic abstinence syndrome in addicted patients. (1986) (5)
- Aging related changes of neurotransmitters in the visual system. (1989) (5)
- Pericentrin expression in Down’s syndrome (2013) (5)
- Dopamine-3 Receptor Modulates Intraocular Pressure (2012) (5)
- The Burden of Comorbidity Between Bipolar Spectrum and Obsessive-Compulsive Disorder in an Italian Community Survey (2020) (5)
- Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network (2017) (5)
- Effects of hyaluronic acid fractions in the rabbit eye. (1990) (4)
- Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy (2022) (4)
- Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates (2022) (4)
- Dihydroergocryptine improves behavioral deficits of aged male rats (1988) (4)
- Endocannabinoids and psychopathology: the therapy inside. (2007) (4)
- Effects of valproic acid derivatives on the acquisition of active avoidance behavior in the rat. (1984) (4)
- Pituitary stalk section transiently impairs the acquisition of shuttle box avoidance behavior (1983) (4)
- Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson’s disease from atypical Parkinsonian syndromes (2020) (4)
- Effects of nicergoline on rabbit electroretinogram during recovery after ischaemia in light and dark. (1997) (4)
- Do Extracellular RNAs Provide Insight into Uveal Melanoma Biology? (2021) (4)
- Effects of pyroglutamic acid on learning and memory processes of the rat (1987) (4)
- Hyperprolactinaemia alleviates behavioral alterations of rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain) (1986) (4)
- Behavioral activity of a short chain ACTH analog (1984) (4)
- A new place conditioning paradigm to study tolerance to opiates in mice. (1999) (4)
- Possible role of prolactin in the modification of medial basal hypothalamic glutamic acid decarboxylase activity. (1981) (4)
- Pharmacokinetic Characterization of Tizanidine Nasal Spray, a Novel Intranasal Delivery Method for the Treatment of Skeletal Muscle Spasm (2013) (4)
- Behavioral effects of phosphatidylserine after perinatal administration in rats (1984) (4)
- Work Productivity and Activity Impairment in Breast Cancer Patients Treated with Capecitabine (2013) (4)
- Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 (2020) (4)
- Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? (2021) (4)
- Intracameral administration of α-MSH increases intraocular pressure in rabbits (1985) (4)
- Dihydroergocristine and memory alterations of aged male rats (1988) (4)
- P.1.d.013 Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist (2006) (4)
- Behavioral effects of arginine in male rats. (1984) (4)
- Plasma concentrations of amitriptyline during single nightly and thrice daily administration. Cross-over study. (1980) (4)
- Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees (2021) (4)
- The dopamine D3 receptor: From preclinical studies to the treatment of psychiatric disorders (2015) (3)
- Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine (2013) (3)
- Lachrymal Concentration of Norfloxacin after a Single Ocular Instillation in Humans (1994) (3)
- Effects of L-α-Glycerylphosphorylcholine on Drug-Induced Behavioral Alterations in Rats (1992) (3)
- Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions (2022) (3)
- The dopaminergic hypothesis for hysterical neurons of the conversion type : a study with sulphide, haloperidol and amineptine (1991) (3)
- Behavioral Effects of Prolactin (1990) (3)
- The Burden of Agoraphobia in Worsening Quality of Life in a Community Survey in Italy (2021) (3)
- Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 (2012) (3)
- Intracameral administration of alpha-MSH increases intraocular pressure in rabbits. (1985) (3)
- Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis (2019) (3)
- Somatic growth in hypophysectomized pituitary-homografted rats is promoted by prolactin (1985) (3)
- Mianserin reduces plasma levels ofβ-endorphin immunoreactivity in depressed patients (1982) (3)
- Effects of thyrotropin-releasing hormone, oxytocin and prolactin on thiopenthal-induced narcosis in rats (1992) (3)
- Effects of risperidone on motor and sexual activity in the rat. (1990) (3)
- Neuroendocrine effects of bromperidol. (1978) (3)
- Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study (2017) (3)
- Monoaminergic regulation of LHRH in the organon vasculosum of lamina terminalis (OVLT). (1980) (3)
- Neuromediators in aging and gastric mucosal injury. (1993) (3)
- Screening for Krabbe disease: The first 2 years' experience (2019) (3)
- Caffeine Protects Against Retinal Inflammation (2022) (3)
- Imputed expression of schizophrenia‐associated genes and cognitive measures in patients with schizophrenia (2022) (2)
- Effects of dihydroergocristine on experimental models of vertigo (1989) (2)
- Plasma viscosity: relation to age, atherogenic diet and suloctidil. (1981) (2)
- SARS-Cov-2 Damage on the Nervous System and Mental Health (2022) (2)
- Molecular features of interaction between VEGF-A and anti-angiogenic molecules (2014) (2)
- [Effect of suloctidil on plasma viscosity in rats on an atherogenic diet]. (1980) (2)
- Prolactin affects central dopamine receptor function: the behavioral model of aged rats. (1988) (2)
- [Rare anomaly of the flexor carpi ulnaris associated with absence of the palmaris longus]. (1979) (2)
- Role of Prolactin in Stress-Induced Biological Modifications in Animals (1990) (2)
- Accelerated recovery of corneal ulcers in rabbits treated with an extract derived from Triticum vulgare (1986) (2)
- David de Wied (1925–2004) (2010) (2)
- Neurotensin-induced miosis: The role of dopaminergic pathways (1990) (2)
- Comparative bioavailability of a new formulation of fluoxetine drops. (2000) (2)
- EFFECTS OF OPIOID DRUGS ON ACTIVE AVOIDANCE BEHAVIOR OF THE RAT (1981) (2)
- Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration (2021) (2)
- The bioinactivation of cerebral TRH by a specific antiserum affects neonatal and adult behavior of the rat (1988) (2)
- Norfloxacin exhibits negligible serum concentrations after repeated conjunctival instillation in children. (1998) (2)
- Pharmacokinetic study of bromperidol after oral and intramuscular administration in rabbits (1990) (1)
- Very low doses of ethanol induce behavioral changes involving dopamine D2 receptors. (2003) (1)
- Hyperprolactinaemia increases intraocular pressure in humans. (1987) (1)
- The promotion of drug innovation in Italy: critical aspects and unsolved problems (2016) (1)
- Therapeutic efficacy of a 30-300 KD protein fraction vs gangliosides in the treatment of diabetic neuropathy. A pilot study (1993) (1)
- Behavioral effects of insulin in the rat (1983) (1)
- Behavioral Changes Induced by Neonatal Administration of TRH Antiserum (1989) (1)
- Faculty Opinions recommendation of Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus. (2020) (1)
- Effects of a pharmacological combination of L-glutamine, DL-phosphorylserine, L-asparagine and pyridoxine on cognitive disturbances in children (1985) (1)
- Forehead Tremor: A Clinical Presentation of Myasthenia Gravis? (2018) (1)
- Effects of betahistine on behavioural alterations induced by hypoxic hypoxia and chronic cerebrovascular insufficiency (1987) (1)
- Behavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress (2006) (1)
- Involvement of Ocular Opiate Receptors in the Regulation of Intraocular Pressure (1982) (1)
- RETINAL BIOAVAILABILITY OF DIFFERENT CURCUMIN ORAL FORMULATIONS: A TRANSLATIONAL STUDY (2018) (1)
- Expression of pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and their receptors in diabetic rat retinas (2010) (1)
- Neurochemical mechanisms of neurotensin-induced miosis. (1989) (1)
- Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1% (2004) (1)
- Effects of TRH on the immune system of newborn rats. (1989) (1)
- The Role of Work in Breast Cancer Patients (2013) (1)
- Interventions against VEGF overexpression, available strategies and future developments (2015) (1)
- [Influence of hematoporphyrin on the tonic or phasic secretion of prolactin]. (1979) (1)
- Dihydroergocristine improves behavioral deficits of aged rats. (1988) (1)
- Endocrine optic neuropathies (1980) (1)
- 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation. (2019) (1)
- [Evaluation of motor behavior in conditions of hyperprolactinemia]. (1981) (1)
- The role of Inositols in PCOS – Opinion Paper (2019) (1)
- Effects of a protein fraction (M.W. 30-300 KD) on the recovery of sensorimotor function in the rat (1992) (1)
- Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta (2021) (1)
- A musician's cramp (2012) (1)
- Behavioral Effects of Prolactin: The Involvement of Brain Dopamine (1983) (1)
- Desenkephalin-gamma-endorphin restores the impaired sensitivity of hypophysectomized rats to small doses of apomorphine. (1986) (1)
- Chronic degeneration of aminergic nerve endings and blood-aqueous barrier (1979) (1)
- Hormonal modulation of central dopamine receptor sensitivity in the postpartum period (1982) (1)
- Nicotine addictions: Neurobiological circuits and pharmacological targets (2013) (1)
- Flunarizine-induced extrapyramidal and depressive symptoms : a clinical model of central dopaminergic impairment (1991) (1)
- Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance (2022) (1)
- VITAMIN D3 AND MESO ZEAXANTHIN PROTECT RETINAL PIGMENTED EPITHELIAL CELLS FROM β-AMYLOID DAMAGE (2020) (1)
- Use of hyaluronic acid in radial keratotomy (1987) (1)
- Indomethacin Eyedrops: Effect of Different Formulations on Ocular Pharmacokinetics in Rabbit (2011) (1)
- Safety Profile of Lutein- Versus Triamcinolone Acetonide–Based Vitreous Staining (2023) (1)
- Erratum: Quality of Life and Urban / Rural Living: Preliminary Results of a Community Survey in Italy (Clinical Practice & Epidemiology in Mental Health (2012) 8 (169-174)) (2013) (1)
- Editorial: Drug Repurposing for COVID-19 Therapy (2021) (1)
- [Evaluation of motor behavior in hyperprolactinemic conditions]. (1981) (1)
- The impact of SARS-Cov-2 on the Nervous system and Mental Health. (2021) (1)
- Prolactin influences sexual behavior during aging. (1985) (1)
- Distribution of rifampicin in ocular tissues after systemic administration (1987) (1)
- In vitro and in vivo antiserotoninergic effects of 1-isopropylnoradreno-chrome-5-monosemicarbazone (Divascan). (1980) (1)
- Effects of levocarnitine acetyl on motor disturbances of diabetic rats (1991) (1)
- [Central muscle-relaxant activity of a new benzodiazepine derivative: prazepam]. (1977) (1)
- [The definition of a reference protocol for the clinical study of vertigo drugs]. (1992) (1)
- Effect of a new ophthalmic hydrocortisone and sodium hyaluronate formulation on two experimental dry eye models (2018) (1)
- Cut‐off scores of blink reflex recovery cycle to differentiate atypical parkinsonisms (2020) (1)
- Effect of suloctidil on blood viscosity in healthy volunteers after forearm occlusion (1981) (1)
- Pilot study of the effects of TRH-T on cognitive processes in schizophrenic patients (1987) (1)
- The anti-inflammatory activity of an extract derived from Triticum vulgare (1986) (1)
- Effects of topical indomethacin, bromfenac, and nepafenac on LPS-induced inflammation (2013) (0)
- Correction: Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation (2013) (0)
- INTERACTIONS OF GASEOUS NEUROMODULATORS IN THE CONTROL OF RABBIT OPHTHALMIC VASCULAR TONE (2014) (0)
- A new potential pharmacological target in diabetic retinopathy: the HuR pathway (2009) (0)
- F1000Prime recommendation of Glutamate and dopamine in schizophrenia: an update for the 21st century. (2017) (0)
- Faculty Opinions recommendation of Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology. (2017) (0)
- Role of Homocysteine in Retinal Neurodegeneration (2015) (0)
- Faculty Opinions recommendation of Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action. (2017) (0)
- Dopamine D3 receptor modulates tissue type plasminogen activator (tPA) activity in mouse brain (2012) (0)
- PROTECTIVE EFFECTS OF TGF-β1 AGAINST AMYLOID-β1-42 OLIGOMERS-INDUCED RETINAL DAMAGE (2016) (0)
- Isoflavones: estrogenic activity, biological effect and bioavailability (2012) (0)
- Faculty Opinions recommendation of A randomized controlled trial of intranasal ketamine in major depressive disorder. (2017) (0)
- P.2.d.022 D3 dopamine receptor knockout mice tested in the forced swim test: increased sensitivity to different antidepressant drugs (2007) (0)
- Induction of tissue plasminogen activator (tPA) by pituitary adenylate cyclase-activating polypeptide (PACAP) in Schwann cell-like cultures (2014) (0)
- The contribution of fats to the average diet in the last century (1871-1880 to 1971-1979). (1980) (0)
- Faculty Opinions recommendation of Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. (2020) (0)
- Experimental acute and chronic ischemia of the retina and chronic treatment with beta-blockers in rabbits: Biochemical evaluations (1992) (0)
- Ocular Hypotensive Effects of Topical Nitric Oxide Synthase Inhibitor in Rabbit (2002) (0)
- Homocysteine in hepatocellular carcinoma with portal vein thrombosis. (2019) (0)
- Dopamine D3 receptor knockout mice exhibit increased hippocampal cAMP response element binding protein (CREB) following acquisition of passive avoidance memory (2013) (0)
- P.1.003 Altered surface dynamics of mGlu5 receptor in a mouse model of Fragile X Syndrome (2014) (0)
- Behavioral effects of a trh analog, rgh 2202, on motor and cognitive alterations in the rat (1992) (0)
- Acidic mammalian chitinase (AMCase): A new target for ocular diseases (2011) (0)
- Cabergoline and IOP: implications for structure-based drug discovery of selective dopaminergic ligands (2013) (0)
- The new Kamoro suspension bridge in Madagascar (2015) (0)
- P.2.024 Cross-talk between GABAergic and dopaminergic system: role of GABAA alpha 6 subunit and D3 receptor in ethanol addiction in mice (2017) (0)
- P.5.080 Gamma-hydroxybutyric acid inhibits ethanol-induced narcosis (2004) (0)
- Dopamine D3 receptor, neurofibromin and amyloid precursor protein expression during learning (2011) (0)
- Faculty Opinions recommendation of Lithium as a treatment for alzheimer's disease: the systems pharmacology perspective. (2019) (0)
- Cannabinoid CB1 receptor blocakade affects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide (2006) (0)
- SELECTIVE ANTI-PlGF PROTECTS HUMAN RETINAL ENDOTHELIAL CELLS AGAINST HIGH GLUCOSE (2019) (0)
- Prenatal stress induces a depressive-like phenotype in adolescent rats: The key role of TGF-β1 pathway (2022) (0)
- What's new in ocular anterior dysgenesis imaging? (2018) (0)
- 483 Screening for Bipolar Disorder and Use of Antidepressant Drugs in Bipolar Depression in Italy (2011) (0)
- The Use of Drugs for Mood Disorders in Italy: Preliminary Results (2009) (0)
- Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells (2012) (0)
- P.1.35 Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A (2008) (0)
- P.535 Cannabinoid CB1 and dopamine D2 receptors transcriptional dysregulation in perinatal delta-9-tetrahydrocannabinol exposed rats and in schizophrenic subjects (2020) (0)
- Faculty Opinions recommendation of Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study. (2020) (0)
- P.1.c.007 Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system (2015) (0)
- Hemin, an Inducer of Heme Oxygenase–1, Lower the Intraocular Pressure in Rabbit (2004) (0)
- Effects of calcitonin-gene related peptide on some behavioral parameters (1992) (0)
- Abstracts of the Third Congress of the International Brain-Gut Society (1993) (0)
- P.2.15 Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides (2004) (0)
- Faculty Opinions recommendation of Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults. (2020) (0)
- P.4.a.016 Genetic deletion of dopamine D3 receptor accelerates the development of tolerance to the anxiolytic effect of diazepam (2014) (0)
- Neurochemical Basis for the Vasoactive Action of Prolactin (1986) (0)
- P.2.29 Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions (2007) (0)
- Effects of pharmacological modulation of the endocannabinoidsystem in a neurodevelopmental animal model of schizophrenia (2016) (0)
- Folate levels in hepatocellular carcinoma patients with portal vein thrombosis (2020) (0)
- The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology (2023) (0)
- Faculty Opinions recommendation of The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. (2017) (0)
- International PhD Program in Neuropharmacology XXIII Cycle NEUROPHARMACOLOGY AND BEHAVIURAL ANIMAL MODELS (2010) (0)
- Faculty Opinions recommendation of Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies? (2020) (0)
- Abstracts of the Società Italiana di Fisiologia of the XIX Riunione Primaverile (Spring Meeting), 15–17 April 1992, Firenze, Italy (2004) (0)
- P.4.07 Peroxisome proliferator-activated receptors (PPARs): new target for attention and memory function (2008) (0)
- F1000Prime recommendation of Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders. (2017) (0)
- Erratum (2019) (0)
- S.12.01 Physiological and therapeutic relevance of constitutive activity at 5-HT2C receptors (2010) (0)
- Behavioral changes in short-term and long term hyperprolacinaemic rats (1983) (0)
- Endocannabinoid system and schizophrenia: behavioral andmolecular changes in neurodevelopmental animal model (2016) (0)
- Interleukin-1 family members in the retina of streptozotocin-injected rats (2013) (0)
- STRIATUM RECEPTOR INTERACTIONS IN THE D3 - FOR A ROLE OF SYNERGISTIC D1 Receptor Heteromers: INDICATIONS 3 D - 1 Identification of Dopamine D Mechanisms of Signal Transduction: (2014) (0)
- Corneal wound healing and nerve regeneration by novel ophthalmic formulations based on cross-linked sodium hyaluronate, taurine, vitamin B6, and vitamin B12 (2023) (0)
- P.3.c.010 Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood (2016) (0)
- PROCEEDINGS of the XVI CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Lecce, Italy June 8-11, 2016 (2016) (0)
- Protective effects of a non-competitive antagonist of NMDA receptors, dextromethorphan, on retinal ischemia of the rabbit (1995) (0)
- Effects of perinatal cannabis exposure on transcriptional regulation of dopamine receptor d2 and cannabinoid receptor 1 in rats at adulthood (2019) (0)
- Opposite actions of female sex steroids on cysteamine-induced gastroduodenal ulceration in the rat (1998) (0)
- Faculty Opinions recommendation of Apathy associated with neurocognitive disorders: Recent progress and future directions. (2020) (0)
- Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death (2014) (0)
- P.1.g.095 Age-related neurodegenerative diseases: what we can learn from glaucoma (2014) (0)
- Faculty Opinions recommendation of Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy. (2020) (0)
- F1000Prime recommendation of Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. (2017) (0)
- Common miRNAs in Alzheimer’s disease and retinal degenerative diseases (2015) (0)
- P43 EFFECTS OF DIETARY CHOLESTEROL ON DEPRESSION IN RATS (2004) (0)
- P.4.06 Behavioral modifications induced by dietary cholesterol in rats (2005) (0)
- Faculty Opinions recommendation of The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia. (2017) (0)
- The effect of chronic stress on the pharmacological effect of antidepressants (1990) (0)
- Selective placental growth factor (PlGF) inhibition: a novel pharmacological approach in diabetic retinopathy (2018) (0)
- Exploring ligands selectivity toward human P2X7 receptor: application to drug discovery in ophthalmology (2016) (0)
- Effects of a hydrocortisone plus sodium hyaluronate solution on wound healing and inflammatory biomarkers in corneal epithelial cells (2018) (0)
- F1000Prime recommendation of Therapeutic potential of cannabinoids in psychosis. (2017) (0)
- Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 (2023) (0)
- S11-3DOPAMINE D3 RECEPTOR-DEPENDENT CHANGES IN GABAA RECEPTOR ALPHA 6 SUBUNIT EXPRESSION CONTROL VOLUNTARY ETHANOL INTAKE (2017) (0)
- P.2.d.017 Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats (2007) (0)
- P.705 Neonatal CB1 receptor blockade differentially affects behavioural responses in normal and prenatally MAM exposed rats (2019) (0)
- P.1.d.012 Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice (2009) (0)
- Faculty Opinions recommendation of Glutamate-Based Drug Discovery for Novel Antidepressants. (2017) (0)
- P.1.c.027 Peroxisome proliferator-activated receptors (PPARs): new target for attention and memory function (2008) (0)
- HUMAN RETINAL PERICYTES PROTECTION: ROLE OF P2X7 RECEPTOR (2017) (0)
- P.2.d.016 The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes (2009) (0)
- Faculty Opinions recommendation of Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia. (2020) (0)
- Drug discovery targeting HuR protein: small molecules to treat diabetic retinopathy (2017) (0)
- Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 (2020) (0)
- Parkin isoforms expression in lung adenocarcinoma (2014) (0)
- Faculty Opinions recommendation of Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People. (2020) (0)
- P.3.d.019 Chronic olanzapine treatment affects intracellular signalling in selected subcellular compartments of rat prefrontal cortex (2006) (0)
- P.5.049 Behavioral effects of ethanol at low doses: The involvement of dopamine D2 receptors (2003) (0)
- Early modulation of the endocannabinoid tone prevents the onset of a schizophrenia-likephenotype (2017) (0)
- P.3.035 NK 2 receptor: A new target for depression therapy (2004) (0)
- Peripubertal treatment with cannabidiol reverses behavioral alterations in ∆9-THC animal model of schizophrenia (2018) (0)
- S.12.03 Altered surface dynamics of mGlu5 receptor in a mouse model of Fragile X Syndrome (2014) (0)
- Correction to: Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees (2021) (0)
- PKC activation affects, via ELAVL1/HuR protein, VEGF expression in pericytic/endothelial coculture (2013) (0)
- Faculty Opinions recommendation of Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling. (2021) (0)
- P.1.28 Modulation of intracellular signaling patwhays by acute swim stress in rat hippocampus (2008) (0)
- Faculty Opinions recommendation of Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review. (2020) (0)
- MRI findings induced by antipsychotic treatment and animal models os chizophrenia-like pathology (2019) (0)
- No somos burócratas, somos UNESCO = We aren't bureaucrats, we are UNESCO (2006) (0)
- Serum Folate deficiency in HCV related Hepatocellular Carcinoma (2022) (0)
- P.6.c.002 Blockade of central serotonin 2B receptors reduces cocaine-induced hyperlocomotion independently of subcortical DA outflow (2014) (0)
- Taurine exerts antioxidant and osmoprotecting activity: an in vitro and in vivo study (2016) (0)
- Role of Pacap and Vip in STZ-induced Diabetic Rats (2011) (0)
- Neurotrasmitter involvement in CRH protection from stress-induced gastric ulcers (1991) (0)
- Evaluation of homocysteine and its metabolic cofactors in patients with non proliferative and proliferative diabetic retinopathy (2013) (0)
- [Dopaminergic system in the retina of rabbits and its interaction with TRH]. (1987) (0)
- Faculty Opinions recommendation of Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole. (2020) (0)
- Therapeutic agent for cataract (1992) (0)
- Faculty Opinions recommendation of Immunotherapeutic approaches for Alzheimer's disease. (2017) (0)
- Neuropeptides fail to affect novelty-induced grooming and learning capacity in dopamine D1-receptor knockout mice (2000) (0)
- BEHAVIORAL CHANGES FOLLOWING PERINATAL ADMINISTRATION OF ANTIDEPRESSANT DRUGS IN THE RAT (1984) (0)
- Ocular pharmacokinetics profile of different hydrocortisone ophthalmic formulations (2018) (0)
- Functional changes detected in different neurodevelopmental animal models of schizophrenia-like phenotypes (2019) (0)
- NDT_A_224754 589..595 (2020) (0)
- Faculty Opinions recommendation of A unifying hypothesis for alzheimer's disease: from plaques to neurodegeneration. (2020) (0)
- Faculty Opinions recommendation of Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms. (2020) (0)
- Effects of Nd-Yag laser vitreolysis on lens and vitreous prostaglandins in the rabbit eye. (1991) (0)
- Comparative study of the anorexic effects of mazindol and fenfluramine (1979) (0)
- Subject Index Vol. 33, 1981 (1981) (0)
- Astrocytic Regulation of Basal Ganglia Dopamine/D2-Dependent Behaviors (2021) (0)
- Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection (2011) (0)
- P.1.006 Molecular basis of alcohol intake: role of D3 dopaminergic receptor (2014) (0)
- FOR A ROLE OF SYNERGISTIC D 1 Receptor Heteromers : INDICATIONS 3 D − 1 Identification of Dopamine D Mechanisms of Signal Transduction : (2008) (0)
- Parkin isoforms expression in gliomas (2014) (0)
- Subject Index Vol. 15, 1986 (2004) (0)
- Response to Letter to the Editor by Dr. Garattini. (2016) (0)
- Faculty Opinions recommendation of Management of behavioral and psychological symptoms of dementia. (2020) (0)
- Therapeutic Potential of Nitric Oxide Modulation in Ocular Diseases: A Focus on Novel NO-Releasing Molecules (2019) (0)
- Behavioral and neurochemical effects of dopaminergic drugs in models of (2002) (0)
- Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model (2009) (0)
- Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside. (2022) (0)
- Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees (2021) (0)
- Cognition Disturbances in Psychiatry: Neurobiology and Treatment (In memory of David de Wied), May 15-16, 2009, Catalina, Italy. (2010) (0)
- Posttranscriptional Regulation of VEGF in Diabetic Retina: Role of the RNA-Binding Protein HuR (2010) (0)
- Faculty Opinions recommendation of Physical frailty correlates with behavioral and psychological symptoms of dementia and caregiver burden in alzheimer's disease. (2020) (0)
- Peripubertal cannabidiol treatment prevents molecular and behavioral changes in neurodevelopmental model of schizophrenia (2018) (0)
- Potential life-style aspects of gingko biloba extract (2002) (0)
- Faculty Opinions recommendation of Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials. (2020) (0)
- P.2.d.024 Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5-HT4 receptor partial agonist SL 65.0155 (2008) (0)
- [Cerebral actions of dihydroergocristine]. (1992) (0)
- Involvement of the endocannabinoid system in a neurodevelopmental model of schizophrenia (2015) (0)
- Contents, Vol. 33, 1996 (1996) (0)
- 70 Effects of variated levels of plasma prolactin on sexual behavior of male rats (1981) (0)
- Faculty Opinions recommendation of Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. (2017) (0)
- P.5.a.006 Flavopiridol, an inhibitor of cyclin-dependent kinase 4, reverses cognitive deficits induced by β-amyloid peptide 1–42 (2014) (0)
- Subject Index Vol. 33, 1996 (1996) (0)
- F1000Prime recommendation of Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries. (2017) (0)
- Faculty Opinions recommendation of Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology. (2020) (0)
- Prolactin induces excessive grooming in the rat (1981) (0)
- P.3.034 Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety (2004) (0)
- Faculty Opinions recommendation of An update on the advancements in the treatment of agitation in Alzheimer's disease. (2020) (0)
- PKCβII/HuR/VEGF Cascade in Experimental Diabetic Retinopathy (2009) (0)
- Faculty Opinions recommendation of The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease. (2020) (0)
- Correction to: Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees (2021) (0)
- F1000Prime recommendation of Cariprazine:New dopamine biased agonist for neuropsychiatric disorders. (2017) (0)
- P.1.21 Selective regulation of cb1 and d2 receptor genes transcription by perinatal delta-9-tetrahydrocannabinol exposure (2019) (0)
- P4.033 The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain (2004) (0)
- Activity of clobetasone butyrate on experimentally induced ocular inflammation in rabbit (1992) (0)
This paper list is powered by the following services:
Other Resources About Filippo Drago
What Schools Are Affiliated With Filippo Drago ?
Filippo Drago is affiliated with the following schools:
